131 related articles for article (PubMed ID: 18199345)
1. Pathological staging of muscle invasive bladder cancer. Is substaging of pT2 tumors really necessary?
Tokgoz H; Turkolmez K; Resorlu B; Kose K; Tulunay O; Beduk Y
Int Braz J Urol; 2007; 33(6):777-83; discussion 783-4. PubMed ID: 18199345
[TBL] [Abstract][Full Text] [Related]
2. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
3. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
[TBL] [Abstract][Full Text] [Related]
4. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
Zhang M; Tao R; Zhang C; Shen Z
Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
[TBL] [Abstract][Full Text] [Related]
5. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
[TBL] [Abstract][Full Text] [Related]
6. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion.
Cheng L; Neumann RM; Scherer BG; Weaver AL; Leibovich BC; Nehra A; Zincke H; Bostwick DG
Cancer; 1999 Jun; 85(12):2638-47. PubMed ID: 10375113
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
8. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
May M; Helke C; Nitzke T; Vogler H; Hoschke B
Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
[TBL] [Abstract][Full Text] [Related]
9. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
Paner GP; Montironi R; Amin MB
Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
11. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
May M; Nitzke T; Helke C; Vogler H; Hoschke B
Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
[TBL] [Abstract][Full Text] [Related]
12. [Radical cystectomy in the treatment of bladder cancer always in due time?].
May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion.
Brimo F; Wu C; Zeizafoun N; Tanguay S; Aprikian A; Mansure JJ; Kassouf W
Hum Pathol; 2013 Jan; 44(1):95-102. PubMed ID: 22939956
[TBL] [Abstract][Full Text] [Related]
14. [Differences in survival of patients with bladder cancer depending on depth of muscle infiltration].
Herranz Amo F; Verdú Tartajo F; Díez Cordero JM; Bielsa Carrillo A; García Burgos J; Subirá Ríos D; Castaño González I
Actas Urol Esp; 2001 Feb; 25(2):110-4. PubMed ID: 11345793
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer.
Colombo R; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Lucianò R; Conti G; Magnani T; Capogrosso P; Conti A; Pasini L; Burgio G; Guazzoni G; Patriarca C
Eur Urol Focus; 2018 Jan; 4(1):87-93. PubMed ID: 28753746
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications.
Zarei S; Frank I; Boorjian SA; Thompson RH; Kim S; Weight C; Tarrell R; Thapa P; Cheville JC
J Urol; 2012 Nov; 188(5):1706-11. PubMed ID: 22998911
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.
Vallo S; Gilfrich C; Burger M; Volkmer B; Boehm K; Rink M; Chun FK; Roghmann F; Novotny V; Mani J; Brisuda A; Mayr R; Stredele R; Noldus J; Schnabel M; May M; Fritsche HM; Pycha A; Martini T; Wirth M; Roigas J; Bastian PJ; Nuhn P; Dahlem R; Haferkamp A; Fisch M; Aziz A
Urol Oncol; 2016 Oct; 34(10):432.e1-8. PubMed ID: 27283218
[TBL] [Abstract][Full Text] [Related]
18. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
Stein JP; Cai J; Groshen S; Skinner DG
J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
[TBL] [Abstract][Full Text] [Related]
20. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
